Digital Genome- Rising advancements for serious health Medications
The digital
genome is predicted to rise due to rising technology advancements and
increased knowledge about the use of genomes for disease diagnosis, such as
cancer, diabetes, and Attention Deficit Hyperactivity Disorder (ADHD). For
example, the National Human Genome Research Institute (NHGRI) initiated a
strategic planning process in February 2018 to build a 2020 vision for genomics
research targeted at speeding up scientific and medical advances. Furthermore,
as part of its strategic planning, the institute will consult with experts and
members of the public to identify other areas of genomics that will broaden the
scope of novel applications in human health and illness treatment.
Increasing inclination towards use of genomes to predict reaction of medication for safe and effective treatment of cancer, Attention Deficit Hyperactivity Disorder (ADHD), and diabetes is expected to boost the market growth. Moreover, the need to choose the most appropriate treatment for ADHD and nutrition profiling where DNA is used to prevent development of chronic diseases is expected to be major growth factor for the digital genome market.
Read more- https://bit.ly/3gm9C5H
Comments
Post a Comment